Liquiritigenin Reduces Blood Glucose Level and Bone Adverse Effects in Hyperglycemic Adult Zebrafish
Diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia that induces other pathologies including diabetic retinopathy and bone disease. Adult <i>Danio rerio</i> (zebrafish) represents a powerful model to study both glucose and bone metabolism. Then, the aim of thi...
Main Authors: | Marta Carnovali, Livio Luzi, Ileana Terruzzi, Giuseppe Banfi, Massimo Mariotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/11/5/1042 |
Similar Items
-
Liquiritigenin reduces osteoclast activity in zebrafish model of glucocorticoid-induced osteoporosis
by: Marta Carnovali, et al.
Published: (2020-08-01) -
Stereospecific pharmacokinetic characterization of liquiritigenin in the rat
by: Samaa Alrushaid, et al.
Published: (2017-01-01) -
Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice
by: Samaa Alrushaid, et al.
Published: (2016-01-01) -
Soybean Meal-Dependent Intestinal Inflammation Induces Different Patterns of Bone-Loss in Adult Zebrafish Scale
by: Marta Carnovali, et al.
Published: (2021-04-01) -
Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models
by: Mahesh Ramalingam, et al.
Published: (2018-11-01)